Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) just unveiled an announcement.
Giant Biogene Holding Co., Ltd, a company incorporated in the Cayman Islands, announced a voluntary increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd. Juzi Holding has purchased 760,000 shares of the company for HK$31.9 million, raising its total shareholding to 54.56% of the company’s issued shares. This move is intended to demonstrate confidence in the company’s future development and to promote its sustainable growth. The increase in shareholding is expected to safeguard the interests of public investors and Juzi Holding may further increase its stake, depending on market conditions and regulatory requirements.
The most recent analyst rating on (HK:2367) stock is a Hold with a HK$58.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Average Trading Volume: 10,129,087
Technical Sentiment Signal: Sell
Current Market Cap: HK$52.22B
For an in-depth examination of 2367 stock, go to TipRanks’ Overview page.